Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2015-04-30
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
NCT01677026
Pathway CH-1 Long-Term Follow-Up
NCT01616511
Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache
NCT01540799
Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
NCT01255813
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
NCT02168764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has the ability to read, comprehend and reliably record information as required by the Protocol.
3. Patient is able to provide written informed consent prior to participation in the study.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Autonomic Technologies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet Neurocenter
Glostrup Municipality, , Denmark
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Klinik und Poliklinik für Neurologie
Dresden, , Germany
Heinrich-Heine-University
Düsseldorf, , Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, , Germany
Klinik für Schmerztherapie, Rotes Kreuz Krankenhaus, Hansteinstr. 29
Kassel, , Germany
Neurologie + Kopfschmerzzentrum Münchner Freiheit
Munich, , Germany
Neurologiska Kliniken-Karolinska UniversitetssjukhusetSolna
Stockholm, , Sweden
University Hospital Zurich, Klinik f. Neurologie, Frauenklinikstr. 26
Zurich, , Switzerland
The Walton Center
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.